Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department.
anticoagulants
atrial fibrillation
emergency department
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
28 Jan 2021
28 Jan 2021
Historique:
entrez:
3
3
2021
pubmed:
4
3
2021
medline:
4
3
2021
Statut:
epublish
Résumé
Atrial fibrillation (AF) is a rhythm disorder observed mostly amongst adults. AF has been regarded as one of the most important medical problems because it leads to thromboembolism and paralysis risks. Although warfarin has been used in the past to cope with this health problem, new oral anticoagulant medicines have replaced it in the last few years. The new oral anticoagulants, namely, dabigatran etexilate, rivaroxaban, and apixaban, are currently being used in daily clinical practice and treatment guidelines. Since AF patients are supposed to receive long-term oral anticoagulant therapy, it is extremely important to provide them with accurate information and appropriate training regarding the treatment to decrease oncoming complications. This is a prospective study involving 168 patients who were admitted to the emergency department with AF and who were using oral anticoagulants. Findings indicate a lack of awareness in the patients regarding the effects and side effects of the drugs they take despite having been informed by the prescribing physician. We believe that informed action by patients with regard to the oral anticoagulants and their side effects will have an impact on the reduction in hospitalization observed. It will also make a substantial contribution to the quality of life of AF patients and to their use of medical services.
Identifiants
pubmed: 33654628
doi: 10.7759/cureus.12963
pmc: PMC7912972
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e12963Informations de copyright
Copyright © 2021, Akman et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Anadolu Kardiyol Derg. 2013 May;13(3):292-3
pubmed: 23443866
Anadolu Kardiyol Derg. 2012 Aug;12(5):384-90
pubmed: 22564270
N Engl J Med. 2011 Sep 15;365(11):981-92
pubmed: 21870978
Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):84-91
pubmed: 20031794
Circulation. 2014 Dec 2;130(23):e199-267
pubmed: 24682347
Patient Educ Couns. 2007 Dec;69(1-3):145-57
pubmed: 17942268
N Engl J Med. 2009 Sep 17;361(12):1139-51
pubmed: 19717844
Stroke. 1995 Aug;26(8):1471-7
pubmed: 7631356
Br J Surg. 2014 Jun;101(7):742-9
pubmed: 24777590
J Gen Intern Med. 2008 Oct;23(10):1589-94
pubmed: 18618191
N Engl J Med. 2011 Sep 8;365(10):883-91
pubmed: 21830957
Cardiology. 2010;116(1):61-9
pubmed: 20502012
Chest. 2008 Jun;133(6 Suppl):160S-198S
pubmed: 18574265